Followers | 276 |
Posts | 56034 |
Boards Moderated | 24 |
Alias Born | 08/29/2007 |
Thursday, October 10, 2024 1:00:38 PM
I am writing a book, American Cars of 1958. Check often for the latest addition. https://investorshub.advfn.com/American-Cars-of-1958-37252/
Recent ADTX News
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 10/25/2024 08:15:31 PM
- Aditxt to Host a Virtual Fireside Chat with Aditxt CEO Amro Albanna and Evofem CEO Saundra Pelletier, Moderated by MD & Media Personality Dr. Drew Pinsky, on October 28, 2024, at 11:30 AM Eastern Time • Business Wire • 10/21/2024 12:15:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/11/2024 09:11:38 PM
- Aditxt’s Acquisition Target Appili Therapeutics Will Hold a Special Meeting of Shareholders on November 6, 2024, to Vote on the Transaction and Secure Appili’s Shareholder Approval • Business Wire • 10/10/2024 12:15:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/09/2024 08:15:07 PM
- Aditxt To Host Stakeholder Update and Q&A Session on Friday, October 11, 2024, at 11:30 AM Eastern Daylight Time • Business Wire • 10/09/2024 02:52:00 PM
- Aditxt Completes Third Parent Equity Investment Under Amended and Restated Merger Agreement With Evofem • Business Wire • 10/08/2024 12:15:00 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 10/07/2024 01:23:41 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 10/07/2024 12:54:36 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/03/2024 08:30:09 PM
- Aditxt Delivers Shareholder Update and 2024 Year-End Plan • Business Wire • 10/03/2024 12:15:00 PM
- Aditxt, Inc. (NASDAQ: ADTX) Announces 1-for-40 Reverse Stock Split Effective at the Open of Trading on October 2, 2024 • Business Wire • 09/27/2024 12:15:00 PM
- Evofem Biosciences Files Preliminary Proxy for Stockholder Approval of the Acquisition by Aditxt • Business Wire • 09/24/2024 12:15:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/23/2024 09:23:03 PM
- Aditxt’s Subsidiary Pearsanta to Collaborate with Evofem Biosciences for Targeted U.S. Launch of Endometriosis Diagnostic in Mid-2025 • Business Wire • 09/20/2024 12:15:00 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 09/16/2024 08:20:07 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 09/16/2024 04:15:14 AM
- Form S-3/A - Registration statement under Securities Act of 1933: [Amend] • Edgar (US Regulatory) • 09/11/2024 09:20:03 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/09/2024 08:15:39 PM
- Aditxt and Evofem Sign Second Amendment to Amended and Restated Merger Agreement, Target Closing of Acquisition in Fourth Quarter of 2024 • Business Wire • 09/09/2024 12:15:00 PM
- Form S-3 - Registration statement under Securities Act of 1933 • Edgar (US Regulatory) • 09/06/2024 09:04:00 PM
- Form 425 - Prospectuses and communications, business combinations • Edgar (US Regulatory) • 09/06/2024 08:16:29 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/06/2024 08:15:09 PM
- Form 8-K/A - Current report: [Amend] • Edgar (US Regulatory) • 09/05/2024 01:22:30 PM
- Form 8-K/A - Current report: [Amend] • Edgar (US Regulatory) • 09/05/2024 01:18:07 PM
Vocodia Enters Medical Alert Industry with Innovative Emergency Response Pendant • VHAI • Oct 25, 2024 8:00 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for Third Quarter 2024 • HYDI • Oct 24, 2024 11:18 AM
VAYK Asserts Goal of Q4 Operationally Profitable and Projects Major 2025 Launch • VAYK • Oct 24, 2024 10:40 AM
CBD Life Sciences Inc. (CBDL) Positioned for Significant Growth Amid Nationwide Marijuana Legalization Push • CBDL • Oct 24, 2024 7:07 AM
ZenaTech, Inc. (NASDAQ: ZENA) Software Company Acquisition • AVXL • Oct 23, 2024 8:03 AM
Forte Minerals to Acquire the Miscanthus Epithermal Gold and Porphyry Copper Prospects in Central Perú with Environmental Drilling Permit (DIA) • CUAU • Oct 23, 2024 7:38 AM